ReShape Lifesciences Reaffirms Commitment To Profitability

Reuters03-04

ReShape Lifesciences Inc :Reshape Lifesciences® Provides Update On 2024 Cost Reduction Plan And Reorganization To Prioritize Commercialization Of Lap-Band® 2.0 Flex.Reshape Lifesciences Inc: 2024 Operating Expenses Expected To Decrease By 55.4% Compared To 2023.Reshape Lifesciences Inc: Significant Cost Reductions Including A Further Reduction In Staff.Reshape Lifesciences Inc - Company Reaffirms Commitment To Profitability.Reshape Lifesciences Inc - Full Implementation Of Plan Is Expected To Result In Lower Operating Expenses Of Approximately $7.9 Million In 2024.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2416147290?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-04 23:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2416147290","market":"us","top_or_hot":-1,"title":"ReShape Lifesciences Reaffirms Commitment To Profitability","media":"Reuters","content":"<html><body><p>ReShape Lifesciences Inc <rsls.o>:Reshape Lifesciences® Provides Update On 2024 Cost Reduction Plan And Reorganization To Prioritize Commercialization Of Lap-Band® 2.0 Flex.Reshape Lifesciences Inc: 2024 Operating Expenses Expected To Decrease By 55.4% Compared To 2023.Reshape Lifesciences Inc: Significant Cost Reductions Including A Further Reduction In Staff.Reshape Lifesciences Inc - Company Reaffirms Commitment To Profitability.Reshape Lifesciences Inc - Full Implementation Of Plan Is Expected To Result In Lower Operating Expenses Of Approximately $7.9 Million In 2024.</rsls.o></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ReShape Lifesciences Reaffirms Commitment To Profitability</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReShape Lifesciences Reaffirms Commitment To Profitability\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-04 23:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.trkd.thomsonreuters.com><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ReShape Lifesciences Inc :Reshape Lifesciences® Provides Update On 2024 Cost Reduction Plan And Reorganization To Prioritize Commercialization Of Lap-Band® 2.0 Flex.Reshape Lifesciences Inc: 2024 ...</p>\n\n<a href=\"https://www.trkd.thomsonreuters.com\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.trkd.thomsonreuters.com","article_id":"2416147290","we_media_id":"1086160438","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2416147290","pubTimestamp":1709564595,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"summary":"ReShape Lifesciences Inc :Reshape Lifesciences Provides Update On 2024 Cost Reduction Plan And Reorganization To Prioritize Commercialization Of Lap-Band 2.0 Flex.Reshape Lifesciences Inc: 2024 Operat","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","RSLS":"ReShape Lifesciences, Inc."},"translate_title":"重塑生命科学重申盈利承诺","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RSLS":0.9},"content_text":"ReShape Lifesciences Inc :Reshape Lifesciences® Provides Update On 2024 Cost Reduction Plan And Reorganization To Prioritize Commercialization Of Lap-Band® 2.0 Flex.Reshape Lifesciences Inc: 2024 Operating Expenses Expected To Decrease By 55.4% Compared To 2023.Reshape Lifesciences Inc: Significant Cost Reductions Including A Further Reduction In Staff.Reshape Lifesciences Inc - Company Reaffirms Commitment To Profitability.Reshape Lifesciences Inc - Full Implementation Of Plan Is Expected To Result In Lower Operating Expenses Of Approximately $7.9 Million In 2024.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2416147290"}